About
Eppin Pharma is currently located in NC BioLabs, 701 West Main Street, Suite 200, Durham, NC 27701.
​
Michael O’Rand, PhD, is an emeritus professor in the Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, School of Medicine. Dr. O’Rand is a reproductive biologist and has more than 40 years of experience in studying mechanisms underlying fertilization. Dr. O’Rand established the in vitro fertilization laboratory in UNC School of Medicine’s North Carolina Memorial Hospital and the first “test tube” baby in North Carolina. He has 5 issued or pending patents and more than 90 peer-reviewed publications. Dr. O’Rand has an AB from the University of California at Berkeley, an MS from Oregon State University, Corvallis, Oregon and a PhD in Biology from Temple University, Philadelphia, PA.

Our Grant
MCI’s grants support IND-enabling milestones that are required for Eppin Pharma to reach its goal of submitting an IND application to the FDA and entering first-in-man studies of their male contraceptive candidate, EP055. The approval of an IND will lead directly to a phase I clinical trial in the NIH contraceptive clinical trial network. Our grants with Eppin cover the methodology used to quantitate EP055 in biological samples, in vitro safety screenings, and a GLP-compliant repeat-dose IV toxicity study.

Press Releases
Male Contraceptive Initiative Invests in Eppin Pharma to Support Clinical Trials for a Non-Hormonal Male Contraceptive​
January 19, 2023

Researcher Receives Second $300,000 Grant for Male Contraception
November 30, 2020​

Eppin Pharma Receives $300,000 Grant for Male Contraception
December 9th, 2019